BRCA Testing (PARP Inhibitors)

BRCA Testing (Olaparib)

 Germline and tumour BRCA testing may now be requested by medical oncologists, to allow determination of likely response to the PARP inhibitor olaparib.

The following resources support that process:

BRCA Testing (Talazoparib)

 Germline BRCA testing may now be requested by medical oncologists, to allow determination of likely response to the PARP inhibitor talazoparib

The following resources support that process: